Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with an
estimated rising prevalence, in concert with the epidemics of obesity and type 2 diabetes …

The underlying mechanism and pathogenesis of NAFLD remain elusive. Although research
effort has advanced the understanding of the natural history, pathogenesis and …

Nonalcoholic fatty liver disease (NAFLD) is quickly becoming one of the most prominent
causes of liver disease worldwide. The increasing incidence of NAFLD is tied to the obesity …

Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to nonalcoholic
steatohepatitis (NASH), leading to fibrosis and potentially cirrhosis, and it is one of the most …

Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease
in developed countries because of the obesity epidemic. The disease increases liver-related …

Non-alcoholic fatty liver disease (NAFLD) encompasses the simple steatosis to more
progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases …

This review summarizes our current understanding of nonalcoholic fatty liver disease
(NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver
disease worldwide with a reported prevalence ranging 6–33%, depending on the studied …

Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder in
the Western world. It is commonly associated with insulin resistance, obesity, dyslipidaemia …

The underlying mechanism and pathogenesis of NAFLD remain elusive despite ongoing
researches to make significant advances in the understanding of its natural history …